Trial | NCT01002729  Report issue

Official Title

Oseltamivir Pharmacokinetics in Morbid Obesity

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    20
This trial asks the question: do people of much greater than average body weight need more of a drug called oseltamivir than current recommendations suggest. Oseltamivir is a drug given to people who have influenza, and currently is also being used to fight the new H1N1 influenza. Some people of larger than average body weight require larger amounts of drugs to see the same effects as others of an average body weight. No studies have ever been conducted looking at the possibility of oseltamivir being one of those drugs. Our Study's hypothesis states that those of an above average body weight will have different amounts of drug in their blood than those of people of normal body weight if they are given the normal amount prescribed for influenza. Our study will give oseltamivir to twenty people for 7 days. Half of the people will be of normal body weight and the others will be of a much higher than normal body weight. Using blood samples the investigators will determine if the amounts of oseltamivir are significantly lower in the blood of patients in the above normal body weight group.
Study Started
Nov 30
2009
Primary Completion
Dec 31
2009
Study Completion
Dec 31
2009
Last Update
Aug 03
2011
Estimate

Other Patients with a BMI < 30 given Oseltamivir

Patients with a BMI < 30 given Oseltamivir

Other Patients with a BMI > 40 given Oseltamivir

Patients with a BMI > 40 given Oseltamivir

Criteria 

Inclusion Criteria:

Males and females aged 18 to 55 years
Written informed consent
Subjects without medical history, physical finding or laboratory finding, which, in the opinion of the investigator, could pose a safety concern or interfere with the protocol.

Exclusion Criteria:

Allergy to oseltamivir
Blood donation within 3 months before oseltamivir administration
Medications that may interfere with the disposition of oseltamivir (e.g. probenecid)
Anemia
Estimated Creatinine clearance < 60 ml/min (As calculated by the modified Cockcroft Gault equation below) Creatinine Clearance= (140-Age) x 1.2 x Adjusted Body weight (x 0.85 if female) Serum Creatinine (umol/L)

Adjusted body weight = Ideal body weight + [0.4 (Actual Bodyweight-Ideal Body Weight)]

Gastrectomy
Enterectomy (or any other surgical procedure that would interfere with absorption)
Clinically significant haematological (RBC count, WBC count, WBC differential count, platelets count and haemoglobin level) or biochemical (ALT, AST, creatinine and urea) abnormalities as per the judgement of the investigator
Clinically significant cardiac conduction abnormality noted on baseline electrocardiogram.
Influenza like illness (fever and/or cough plus one of the following sore throat, fatigue, myalgia, headache) within 7 days of enrolment
Pregnancy
Inability to consume study meals provided due to special dietary requirements such as food allergies.
No Results Posted